002864 盘龙药业
交易中 07-09 14:25:00
资讯
新帖
简况
创新药概念震荡拉升，盘龙药业一度涨超9%
证券之星 · 06-23
创新药概念震荡拉升，盘龙药业一度涨超9%
盘龙药业：截至2026年一季度公司已完成509个中药配方颗粒品种备案
证券之星 · 06-04
盘龙药业：截至2026年一季度公司已完成509个中药配方颗粒品种备案
盘龙药业（002864）披露向2026年股票期权激励计划激励对象授予股票期权的公告，6月1日股价上涨1.91%
证券之星 · 06-01
盘龙药业（002864）披露向2026年股票期权激励计划激励对象授予股票期权的公告，6月1日股价上涨1.91%
盘龙药业（002864）披露2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况自查报告，5月27日股价下跌0.39%
证券之星 · 05-27
盘龙药业（002864）披露2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况自查报告，5月27日股价下跌0.39%
盘龙药业（002864）披露2026年股票期权激励计划（草案），5月13日股价上涨2.96%
证券之星 · 05-13
盘龙药业（002864）披露2026年股票期权激励计划（草案），5月13日股价上涨2.96%
盘龙药业（002864）披露召开2025年年度股东会的通知，5月6日股价上涨0.2%
证券之星 · 05-06
盘龙药业（002864）披露召开2025年年度股东会的通知，5月6日股价上涨0.2%
每周股票复盘：盘龙药业（002864）一季度净利降30.36%
证券之星 · 05-03
每周股票复盘：盘龙药业（002864）一季度净利降30.36%
盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%
证券之星 · 04-27
盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%
盘龙药业：坚持以高质量经营夯实基本面
证券之星 · 04-23
盘龙药业：坚持以高质量经营夯实基本面
盘龙药业：公司高度重视股东回报与价值维护
证券之星 · 04-02
盘龙药业：公司高度重视股东回报与价值维护
股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元
证券之星 · 03-24
股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元
盘龙药业：3月12日董事朱文锋减持股份合计2.25万股
证券之星 · 03-13
盘龙药业：3月12日董事朱文锋减持股份合计2.25万股
盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书
证券之星 · 03-03
盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书
股市必读：盘龙药业（002864）2月25日董秘有最新回复
证券之星 · 02-26
股市必读：盘龙药业（002864）2月25日董秘有最新回复
盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%
证券之星 · 02-05
盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%
盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%
证券之星 · 02-03
盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%
盘龙药业(002864.SZ)：氟比洛芬贴剂获准开展临床试验
智通财经 · 02-02
盘龙药业(002864.SZ)：氟比洛芬贴剂获准开展临床试验
股市必读：盘龙药业（002864）1月26日董秘有最新回复
证券之星 · 01-27
股市必读：盘龙药业（002864）1月26日董秘有最新回复
异动快报：盘龙药业（002864）1月7日10点42分触及涨停板
证券之星 · 01-07
异动快报：盘龙药业（002864）1月7日10点42分触及涨停板
每周股票复盘：盘龙药业（002864）拟将节余募资5409.79万补流
证券之星 · 01-03
每周股票复盘：盘龙药业（002864）拟将节余募资5409.79万补流
加载更多
公司概况
公司名称：
陕西盘龙药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2017-11-16
主营业务：
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是自产中成药、中药饮片、医药商业配送、大健康产品。公司曾荣获“国家级绿色工厂”、“CNAS实验室认证”、“全国文明单位”、ESG治理先锋等多项国家级荣誉。
发行价格：
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":30.1,"timestamp":1783578300000,"preClose":29.46,"halted":0,"volume":7746633,"delay":0,"changeRate":0.0217,"floatShares":73685200,"shares":106000000,"eps":0.8167,"marketStatus":"交易中","change":0.64,"latestTime":"07-09 14:25:00","open":29.29,"high":31.68,"low":29,"amount":234000000,"amplitude":0.091,"askPrice":30.17,"askSize":4,"bidPrice":30.1,"bidSize":70,"shortable":0,"etf":0,"ttmEps":0.8167,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1783580400000},"marketStatusCode":2,"adr":0,"adjPreClose":29.46,"symbolType":"stock","openAndCloseTimeList":[[1783560600000,1783567800000],[1783573200000,1783580400000]],"highLimit":32.41,"lowLimit":26.51,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":106280960,"isCdr":false,"pbRate":1.83,"roa":"--","peRate":36.855639,"roe":"1.28%","epsLYR":0.92,"committee":0.407115,"marketValue":3199000000,"turnoverRate":0.1051,"status":0,"floatMarketCap":2218000000},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2645888742","title":"创新药概念震荡拉升，盘龙药业一度涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645888742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645888742?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:14","pubTimestamp":1782195288,"startTime":"0","endTime":"0","summary":"6月23日，创新药概念震荡拉升，盘龙药业一度大涨超9%。公司层面，盘龙药业是集药材规范化种植、药品生产、研发、销售为一体的现代化高新技术企业，以医药制造为核心主营业务，产业链涵盖现代中药、医药商业和大健康。长城证券指出，盘龙药业作为风湿骨科类中药龙头企业，将持续受益政策红利、人口老龄化趋势加速和消费升级趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026062300019848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","06978","BK0239","159992","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640139113","title":"盘龙药业：截至2026年一季度公司已完成509个中药配方颗粒品种备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2640139113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640139113?lang=zh_cn&edition=full","pubTime":"2026-06-04 11:34","pubTimestamp":1780544064,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业06月03日在投资者关系平台上答复投资者关心的问题。截至2026年一季度公司已完成509个中药配方颗粒品种备案，智能化产线已全面建成投产，具备全品种量产能力，同步组建了专项业务中心，依托现有覆盖全国的成熟营销网络，公司正积极推进全国各省份的挂网准入工作。后续公司也将持续根据行业政策、市场变化动态优化经营策略，稳步推进中药配方颗粒业务落地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400014399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640495861","title":"盘龙药业（002864）披露向2026年股票期权激励计划激励对象授予股票期权的公告，6月1日股价上涨1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640495861","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640495861?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:03","pubTimestamp":1780308189,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，盘龙药业报收于29.33元，较前一交易日上涨1.91%，最新总市值为31.17亿元。公司于近日披露《关于向2026年股票期权激励计划激励对象授予股票期权的公告》。公告显示，陕西盘龙药业集团股份有限公司于2026年5月29日召开董事会，确定当日为股票期权授予日，向60名激励对象授予37.35万份股票期权，行权价格为31.11元/份。本次授予符合公司股权激励计划规定条件，不会导致股权分布不符合上市条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100028562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638850542","title":"盘龙药业（002864）披露2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况自查报告，5月27日股价下跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638850542","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638850542?lang=zh_cn&edition=full","pubTime":"2026-05-27 17:36","pubTimestamp":1779874617,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，盘龙药业报收于28.45元，较前一交易日下跌0.39%，最新总市值为30.24亿元。该股当日开盘28.55元，最高28.72元，最低28.0元，成交额达4864.33万元，换手率为2.33%。盘龙药业于近日披露《关于公司2026年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告》。公司未发现内幕信息泄露或利用内幕信息进行交易的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700034733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635430783","title":"盘龙药业（002864）披露2026年股票期权激励计划（草案），5月13日股价上涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635430783","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635430783?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:29","pubTimestamp":1778668186,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，盘龙药业报收于31.61元，较前一交易日上涨2.96%，最新总市值为33.6亿元。该股当日开盘31.31元，最高32.05元，最低31.27元，成交额达1.3亿元，换手率为5.58%。近日，盘龙药业披露《2026年股票期权激励计划（草案）》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300034608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633275186","title":"盘龙药业（002864）披露召开2025年年度股东会的通知，5月6日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633275186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633275186?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:12","pubTimestamp":1778062323,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，盘龙药业报收于30.3元，较前一交易日上涨0.2%，最新总市值为32.2亿元。该股当日开盘30.38元，最高30.43元，最低30.1元，成交额达5557.01万元，换手率为2.49%。公司于近日披露《关于召开2025年年度股东会的通知》。公告显示，陕西盘龙药业集团股份有限公司将于2026年5月26日召开2025年年度股东会，会议由董事会召集，现场会议地点为西安市灞桥区现代纺织产业园灞柳二路2801号公司二楼会议室。股权登记日为2026年5月19日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600029414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608350","title":"每周股票复盘：盘龙药业（002864）一季度净利降30.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608350","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608350?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:57","pubTimestamp":1777766227,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，盘龙药业报收于30.24元，较上周的30.19元上涨0.17%。本周，盘龙药业4月30日盘中最高价报30.5元。本周关注点来自业绩披露要点：盘龙药业2026年一季报显示，归母净利润同比下降30.36%。股本股东变化截至2026年3月31日，盘龙药业股东户数为2.2万户，较2025年12月31日减少1890户，减幅7.91%。公司公告汇总公司2026年第一季度营业收入为222,541,696.37元，同比下降11.06%；归母净利润为21,760,948.70元，同比下降30.36%；扣非净利润为20,014,169.48元，同比下降30.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630039073","title":"盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630039073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630039073?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:29","pubTimestamp":1777300174,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，盘龙药业报收于30.33元，较前一交易日上涨0.46%，最新总市值为32.24亿元。该股当日开盘30.24元，最高30.42元，最低29.72元，成交额达7362.07万元，换手率为3.32%。近日，陕西盘龙药业集团股份有限公司披露2026年第一季度报告。报告显示，本报告期营业收入为222,541,696.37元，较上年同期下降11.06%；归属于上市公司股东的净利润为21,760,948.70元，同比下降30.36%；归属于上市公司股东的扣除非经常性损益的净利润为20,014,169.48元，同比下降30.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700046763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629834106","title":"盘龙药业：坚持以高质量经营夯实基本面","url":"https://stock-news.laohu8.com/highlight/detail?id=2629834106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629834106?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:52","pubTimestamp":1776948728,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业04月22日在投资者关系平台上答复投资者关心的问题。坚持以高质量经营夯实基本面，常态化开展投资者沟通，严格执行持续稳定分红政策，积极传递公司长期价值。公司严格遵守信息披露相关法律法规及监管要求，不存在应披露而未披露的重大事项，所有重大信息均及时、公平、合规履行披露义务。相关项目进展公司将严格按照规定及时公告，请以官方披露信息为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300059146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624571232","title":"盘龙药业：公司高度重视股东回报与价值维护","url":"https://stock-news.laohu8.com/highlight/detail?id=2624571232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624571232?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:36","pubTimestamp":1775118982,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业(002864)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价低迷，10年前差不多就是这价位，跟经营业绩持续增长不匹配，处于低估状态，公司账上现金充足，建议董事会为股东着想，拿出3–4亿元回购注销公司股份？盘龙药业回复：尊敬的投资者您好！感谢您的关注和宝贵建议。公司高度重视股东回报与价值维护，资金统筹安排将兼顾主业经营、研发创新与长期发展，持续夯实内在价值。公司将严格依规履行审议程序及信息披露义务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200027208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621295086","title":"股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621295086","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621295086?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:57","pubTimestamp":1774292228,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，盘龙药业报收于31.34元，下跌7.82%，换手率8.07%，成交量5.99万手，成交额1.92亿元。交易信息汇总股价提醒3月23日盘龙药业收盘报31.34元，跌7.82%，当日成交598.54万元。前10个交易日资金流向情况：主力资金累计净流入1130.12万元，股价累计下跌7.5%。资金流向3月23日主力资金净流入734.79万元；游资资金净流出1563.32万元；散户资金净流入828.53万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619199639","title":"盘龙药业：3月12日董事朱文锋减持股份合计2.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619199639","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619199639?lang=zh_cn&edition=full","pubTime":"2026-03-13 19:01","pubTimestamp":1773399674,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月13日市场公开信息、上市公司公告及交易所披露数据整理，盘龙药业（002864）最新董监高及相关人员股份变动情况：2026年3月12日公司董事朱文锋共减持公司股份2.25万股，占公司总股本为0.0212%。变动期间公司股价下跌1.91%，3月12日当日收盘报33.3元。盘龙药业近半年内的董监高及核心技术人员增减持详情如下：盘龙药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300033464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616346888","title":"盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346888","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616346888?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:19","pubTimestamp":1772533197,"startTime":"0","endTime":"0","summary":"盘龙药业公告称，公司收到国家药品监督管理局颁发的硫酸氨基葡萄糖胶囊的《药品注册证书》。根据米内网数据显示，2024年国内城市和县级公立医院、城市和网上药店、城市社区医院和乡镇卫生院的销售金额约33.62亿元人民币。本次获批将进一步丰富公司非处方药管线与骨科慢病产品矩阵，有利于公司拓展院外市场、推进渠道终端下沉，提升品牌在基层及零售终端的影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300033639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614703759","title":"股市必读：盘龙药业（002864）2月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614703759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614703759?lang=zh_cn&edition=full","pubTime":"2026-02-26 01:47","pubTimestamp":1772041632,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘，盘龙药业报收于37.61元，下跌0.66%，换手率4.95%，成交量3.67万手，成交额1.38亿元。董秘最新回复投资者： 公司对腰间盘突出，脊椎骨3，4，5节压迫神经，从而导致人体站不直，神经痛，走路难＇痛的问题？公司深耕主业，已形成包括药品研发、生产及销售在内的完整业务体系。相关产品主要依据获批适应症用于相应病症的治疗。当日关注点来自交易信息汇总：2月25日主力资金净流出326.48万元，散户资金净流入262.32万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600000965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609309344","title":"盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309344?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301035,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，盘龙药业报收于36.46元，较前一交易日上涨3.05%，最新总市值为38.75亿元。该股当日开盘35.41元，最高36.9元，最低35.23元，成交额达2.69亿元，换手率为9.99%。近日，陕西盘龙药业集团股份有限公司发布《关于注销部分募集资金账户的公告》。公司称已按规定履行信息披露义务，确保内容真实、准确、完整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608316877","title":"盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608316877","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608316877?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:25","pubTimestamp":1770128723,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，盘龙药业报收于35.35元，较前一交易日上涨0.28%，最新总市值为37.57亿元。近日，盘龙药业发布《关于董事减持股份预披露公告》。其计划在公告披露之日起15个交易日后的3个月内，通过集中竞价方式减持不超过22,500股，占剔除公司已回购股份的总股本比例不超过0.0212%。减持期间为2026年3月5日至2026年6月4日，减持价格将按市场价格确定。本次减持符合其在任职期间的相关承诺，不存在违反承诺的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608308852","title":"盘龙药业(002864.SZ)：氟比洛芬贴剂获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2608308852","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608308852?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:31","pubTimestamp":1770024709,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盘龙药业(002864.SZ)公告，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意氟比洛芬贴剂开展临床试验。相关适应症为下述疾病及症状的镇痛、消炎：骨关节炎、肩关节周围炎、腱炎及腱鞘炎、腱周炎、肱骨外上髁炎(如网球肘等)、肌肉痛、外伤后的肿胀及疼痛。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606407652","title":"股市必读：盘龙药业（002864）1月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606407652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606407652?lang=zh_cn&edition=full","pubTime":"2026-01-27 02:09","pubTimestamp":1769450953,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，盘龙药业报收于37.11元，上涨0.0%，换手率8.4%，成交量6.23万手，成交额2.33亿元。公司将严格按照相关法律法规及时履行信息披露义务，敬请关注公司后续公告。来自交易信息汇总：散户资金净流入211.0万元，表明个人投资者今日整体偏向买入。交易信息汇总资金流向1月26日主力资金净流出847.05万元；游资资金净流入636.05万元；散户资金净流入211.0万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700001719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601281678","title":"异动快报：盘龙药业（002864）1月7日10点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601281678?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:45","pubTimestamp":1767753917,"startTime":"0","endTime":"0","summary":"证券之星1月7日盘中消息，10点42分盘龙药业触及涨停板。其所属行业中药目前下跌。该股为创新药，医药，肝炎概念概念热股，当日创新药概念上涨1.45%，医药概念上涨0.64%，肝炎概念概念上涨0.02%。1月6日的资金流向数据方面，主力资金净流出32.87万元，占总成交额0.35%，游资资金净流出117.77万元，占总成交额1.24%，散户资金净流入150.63万元，占总成交额1.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700010818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600067020","title":"每周股票复盘：盘龙药业（002864）拟将节余募资5409.79万补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2600067020","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600067020?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:21","pubTimestamp":1767381669,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，盘龙药业报收于30.84元，较上周的31.66元下跌2.59%。本周，盘龙药业12月29日盘中最高价报31.66元。公司公告汇总：公司实际控制人谢晓林及其配偶为5000万元银行贷款无偿提供连带责任担保。公司公告汇总中泰证券对盘龙药业拟将“中药配方颗粒研发及产业化项目”结项，并将节余募集资金5,409.79万元永久补充流动资金事项无异议。公司拟向中国农业银行柞水县支行申请5000万元短期流动资金贷款，年化利率2.10%，期限6个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783578304293,"stockEarnings":[{"period":"1week","weight":0.1001},{"period":"1month","weight":0.0462},{"period":"3month","weight":-0.1051},{"period":"6month","weight":-0.1429},{"period":"1year","weight":0.0178},{"period":"ytd","weight":-0.0447}],"compareEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0012},{"period":"6month","weight":-0.0363},{"period":"1year","weight":0.1354},{"period":"ytd","weight":0.0005}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22008人(较上一季度减少7.91%)","perCapita":"3348股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"10628万元","survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是自产中成药、中药饮片、医药商业配送、大健康产品。公司曾荣获“国家级绿色工厂”、“CNAS实验室认证”、“全国文明单位”、ESG治理先锋等多项国家级荣誉。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}